Patents by Inventor Judith Kapp

Judith Kapp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Noscapine derivatives as adjuvant compositions and methods of use thereof
    Patent number: 7090853
    Abstract: An adjuvant composition comprising noscapine and its derivatives, for use in the treatment of tumors, cancer, as an adjuvant for vaccines.
    Type: Grant
    Filed: November 6, 2002
    Date of Patent: August 15, 2006
    Assignee: Emory University
    Inventors: Judith Kapp, Yong Ke
  • Method of inhibiting immune system destruction of transplanted viable cells
    Patent number: 7041634
    Abstract: This invention provides a method of inhibiting viable cells transplanted into a subject from being destroyed by the subject's immune system which comprises: a) containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; and b) treating the subject with a substance which inhibits an immune-system costimulation event in an amount effective to inhibit the subject's immune system from responding to said contained cells or tissue. In one embodiment, the substance which inhibits an immune-system costimulation event is CTLA4.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: May 9, 2006
    Assignees: Emory University, Bristol Myers-Squibb Company
    Inventors: Collin J. Weber, Mary K. Hagler, Peter S. Linsley, Judith A. Kapp, Susan A. Safley
  • Noscapine derivatives as adjuvant compositions and methods of use thereof
    Publication number: 20060018926
    Abstract: An adjuvant composition comprising noscapine and its derivatives, for use in the treatment of tumors, cancer, as an adjuvant for vaccines.
    Type: Application
    Filed: July 8, 2005
    Publication date: January 26, 2006
    Inventors: Judith Kapp, Yong Ke
  • METHOD OF INHIBITING IMMUNE SYSTEM DESTRUCTION OF TRANSPLANTED VIABLE CELLS
    Publication number: 20040047890
    Abstract: This invention provides a method of inhibiting viable cells transplanted into a subject from being destroyed by the subject's immune system which comprises: a) containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; and b) treating the subject with a substance which inhibits an immune-system costimulation event in an amount effective to inhibit the subject's immune system from responding to said contained cells or tissue. In one embodiment, the substance which inhibits an immune-system costimulation event is CTLA4.
    Type: Application
    Filed: March 27, 1998
    Publication date: March 11, 2004
    Inventors: COLLIN J. WEBER, MARY K. HAGLER, PETER S. LINSLEY, JUDITH A. KAPP, SUSAN A. SAFLEY
  • Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents
    Patent number: 6673814
    Abstract: The present invention relates to methods useful for the treatment of neoplastic diseases, tumor cells, and the treatment of cancer delivering compounds of the formula The invention provides various methods of delivering such compounds, combinations of treatments, and altering such compounds to enhance their effectiveness.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: January 6, 2004
    Assignee: Emory University
    Inventors: Harish C. Joshi, Keqiang Ye, Judith Kapp, Jaren Landen, David Archer, Cheryl Armstrong, Fuqiang Liu
  • Noscapine derivatives as adjuvant compositions and methods of use thereof
    Publication number: 20030130344
    Abstract: An adjuvant composition comprising noscapine and its derivatives, for use in the treatment of tumors, cancer, as an adjuvant for vaccines.
    Type: Application
    Filed: November 6, 2002
    Publication date: July 10, 2003
    Inventors: Judith Kapp, Yong Ke
  • Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents
    Publication number: 20020137762
    Abstract: The present invention relates to methods useful for the treatment of neoplastic diseases, tumor cells, and the treatment of cancer delivering compounds of the formula 1
    Type: Application
    Filed: January 25, 2002
    Publication date: September 26, 2002
    Inventors: Harish C. Joshi, Keqiang Ye, Judith Kapp, Jaren Landen, David Archer, Cheryl Armstrong, Fuqiang Liu
  • Noscapine and noscapine derivatives, useful as anticancer agents
    Patent number: 6376516
    Abstract: Compounds such as formula (I) are useful in the treatment of tumor cells and the treatment of cancer.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: April 23, 2002
    Assignee: Emory University
    Inventors: Harish C. Joshi, Ye Keqiang, Judith Kapp, Fuqiang Liu
  • Method for gene therapy involving suppression of an immune response
    Patent number: 6093699
    Abstract: A method for specifically suppressing the capacity of a mammal receiving gene therapy to mount an immune response to a given expressed gene of the deficient gene in question, which response is caused by the administration of "foreign" DNA encoding an antigenic protein or vectors comprising such DNA for expression of the deficient gene in the patient receiving gene therapy.
    Type: Grant
    Filed: November 10, 1994
    Date of Patent: July 25, 2000
    Assignees: The University of Manitoba, Emory University
    Inventors: Alec Sehon, Judith A. Kapp, Glen M. Lang, Yong Ke